Detalhe da pesquisa
1.
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat
; 177(1): 115-125, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152327
2.
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Eur J Cancer Care (Engl)
; 27(4): e12861, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869823
3.
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort.
Clin Transl Oncol
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519708
4.
Comparison of alternating pressure mattresses and overlays for prevention of pressure ulcers in ventilated intensive care patients: a quasi-experimental study.
J Adv Nurs
; 69(9): 2099-106, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23347198
5.
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
Cells
; 12(6)2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980184
6.
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.
Drug Resist Updat
; 14(4-5): 212-23, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21600837
7.
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
Sci Rep
; 12(1): 14439, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002559
8.
Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth.
J Cell Physiol
; 226(1): 52-7, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20658522
9.
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.
Breast Cancer Res Treat
; 126(2): 355-64, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20458531
10.
Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer.
Anticancer Drugs
; 22(3): 283-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21150776
11.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Clin Cancer Res
; 27(2): 645-655, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106291
12.
Dynamic emergence of the mesenchymal CD44(pos)CD24(neg/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin).
Biochem Biophys Res Commun
; 397(1): 27-33, 2010 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20470755
13.
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
Neuro Oncol
; 22(12): 1851-1861, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328662
14.
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
J Drug Assess
; 8(1): 62-69, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069129
15.
Macrovascular Networks on Contrast-Enhanced Magnetic Resonance Imaging Improves Survival Prediction in Newly Diagnosed Glioblastoma.
Cancers (Basel)
; 11(1)2019 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30646519
16.
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Int J Oncol
; 33(6): 1165-76, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19020749
17.
Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapies.
Genes Chromosomes Cancer
; 50(4): 284-90, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21319263
18.
Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab.
Neurooncol Pract
; 4(1): 15-23, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385992
19.
Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).
Cancer Epidemiol
; 50(Pt A): 1-8, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738268
20.
Pseudoprogression as an adverse event of glioblastoma therapy.
Cancer Med
; 6(12): 2858-2866, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29105360